ORBIMED ADVISORS LLC: ETRA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ETRA, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 6,885,170 ETRA shares at 2026-09-30 per its 13F-HR filed 2026-11-16, and reported 7,449,857 shares in a Form 4 filed 2026-11-10.
Estimated current stake: 7,449,857 shares
Estimated from Form 4 of 2026-11-10. As of 2026-11-10, Form 4 0000947871-26-001010.
Shares are the reporting owners' post-transaction amount in the lines that filing reports.
Percent of portfolio stays on the 13F for 2026-09-30.
- transaction date2026-11-10F4 7,449,857 sharesTransaction change +2,000 shares
(code P, bought) at $8.45.
Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,255,278 shares
- Indirect See footnotes : 2,194,579 shares
- transaction date2026-11-10F4 7,447,857 sharesTransaction change +20,700 shares
(code P, bought) at $8.45.
Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,255,278 shares
- Indirect See footnotes : 2,192,579 shares
- transaction date2026-11-09F4 7,427,157 sharesTransaction change +16,000 shares
(code P, bought) at $8.24.
Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,234,578 shares
- Indirect See footnotes : 2,192,579 shares
- transaction date2026-11-09F4 7,411,157 sharesTransaction change +4,000 shares
(code P, bought) at $8.24.
Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,234,578 shares
- Indirect See footnotes : 2,176,579 shares
- transaction date2026-11-06F4 7,407,157 sharesTransaction change +39,600 shares
(code P, bought) at $7.85.
Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,230,578 shares
- Indirect See footnotes : 2,176,579 shares
- transaction date2026-11-06F4 7,367,557 sharesTransaction change +9,816 shares
(code P, bought) at $7.85. Different basis (another filing's ownership lines).
Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,230,578 shares
- Indirect See footnotes : 2,136,979 shares
- transaction date2026-11-05F4 7,357,741 sharesTransaction change +125,200 shares
(code P, bought) at $7.31.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,220,762 shares
- Indirect See footnotes : 2,136,979 shares
- transaction date2026-11-05F4 7,232,541 sharesTransaction change +30,891 shares
(code P, bought) at $7.31.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,220,762 shares
- Indirect See footnotes : 2,011,779 shares
- transaction date2026-11-04F4 7,201,650 sharesTransaction change +20,000 shares
(code P, bought) at $7.07.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,189,871 shares
- Indirect See footnotes : 2,011,779 shares
- transaction date2026-11-04F4 7,181,650 sharesTransaction change +5,000 shares
(code P, bought) at $7.07.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,189,871 shares
- Indirect See footnotes : 1,991,779 shares
- transaction date2026-11-04F4 7,176,650 sharesTransaction change +37,100 shares
(code P, bought) at $7.78.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,184,871 shares
- Indirect See footnotes : 1,991,779 shares
- transaction date2026-11-04F4 7,139,550 sharesTransaction change +9,267 shares
(code P, bought) at $7.78.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,184,871 shares
- Indirect See footnotes : 1,954,679 shares
- transaction date2026-11-03F4 7,130,283 sharesTransaction change +98,600 shares
(code P, bought) at $7.88.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,175,604 shares
- Indirect See footnotes : 1,954,679 shares
- transaction date2026-11-03F4 7,031,683 sharesTransaction change +24,400 shares
(code P, bought) at $7.88.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,175,604 shares
- Indirect See footnotes : 1,856,079 shares
- transaction date2026-11-03F4 7,007,283 sharesTransaction change +97,800 shares
(code P, bought) at $7.84.
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,151,204 shares
- Indirect See footnotes : 1,856,079 shares
- transaction date2026-11-03F4 6,909,483 sharesTransaction change +24,313 shares
(code P, bought) at $7.84. Different basis (the reporting owners' lines in a Form 3, 4 or 5).
Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
Accepted , ingested- Indirect See footnotes : 5,151,204 shares
- Indirect See footnotes : 1,758,279 shares
- period ended2026-09-3013F 6,885,170 sharesShare basis changed not comparable
Different basis (13F positions of the group's filers). 1.42% of the 13F portfolio, value $77,458,163.
13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
Accepted , ingested - event date2026-09-2113D 6,885,170 sharesChange vs previous stake not available
11% of the class.
13D 0000947871-26-000898 filed by ORBIMED ADVISORS LLC
Accepted , ingestedA 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.